Search Results - "Kok, T. C."

The benefits and risks of beetroot juice consumption: a systematic review by Zamani, H., de Joode, M. E. J. R., Hossein, I. J., Henckens, N. F. T., Guggeis, M. A., Berends, J. E., de Kok, T. M. C. M., van Breda, S. G. J.

“…Beetroot juice (BRJ) has become increasingly popular amongst athletes aiming to improve sport performances. BRJ contains high concentrations of nitrate, which…”
Get full text

Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer by van der Burg, M.E.L, Onstenk, W, Boere, I.A, Look, M, Ottevanger, P.B, de Gooyer, D, Kerkhofs, L.G.M, Valster, F.A.A, Ruit, J.B, van Reisen, A.G.P.M, Goey, S.H, van der Torren, A.M.E, ten Bokkel Huinink, D, Kok, T.C, Verweij, J, van Doorn, H.C

“…Abstract Background Weekly paclitaxel/carboplatin might improve survival in platinum-resistant epithelial ovarian cancer (EOC). We compared efficacy of…”
Get full text

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy by POLES, M. B, HOP, W. C. J, KOK, T. C, ESKENS, Falm, VAN DER BURG, M. E. L, SPLINTER, T. A. W, SIERSEMA, P. D, TILANUS, H. W, STOTER, G, VAN DER GAAST, A

“…The objective of this study was to identify prognostic factors for survival in patients with advanced oesophageal cancer, who are treated with cisplatin-based…”
Get full text

Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial by Grimaldi, C, Bleiberg, H, Gay, F, Messner, M, Rougier, P, Kok, T C, Cirera, L, Cervantes, A, De Greve, J, Paillot, B, Buset, M, Nitti, D, Sahmoud, T, Duez, N, Wils, J

“…The aim of the study was to evaluate the efficacy of antiandrogen therapy on overall survival and response in unresectable hepatocellular carcinoma (HCC). A…”
Get more information

An insight into clinicians’ practices in breaking bad news of oral cancer diagnosis by Mohd Desa, S.N.F., Doss, J.G., Kadir, K., Ch’ng, L.L., Kok, T.C., Jelon, M.A., Yahya, M.R., Parumo, R., Chong, S.M.Y., Shim, C.K.

“…Communication is an integral component of effective healthcare delivery to patients, and this includes breaking bad news (BBN). However, clinicians in…”
Get full text

Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with α-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial by Wagener, D.J.T, Wils, J.A, Kok, T.C, Planting, A, Couvreur, M.L, Baron, B

“…A randomised phase II study of 5-fluorouracil (5-FU) plus cisplatin (CDDP) with or without α-interferon 2b was performed in patients with pancreatic cancer…”
Get full text

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1 by VAN DER GAAST, A, SCHOENMAKERS, C. H. H, KOK, T. C, BLIJENBERG, B. G, CORNILLIE, F, SPLINTER, T. A. W

“…The Cyfra 21.1 assay is a newly developed test which measures in serum a fragment of cytokeratin 19. We evaluated this marker in 212 patients with…”
Get full text

Chemotherapy in oesophageal cancer by Kok, T.C.

Get full text

No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area by Kok, T.C., Nooter, K., Tjong-A-Hung, S.P., Smits, H.L., Schegget, J.Ter

“…Controversial results regarding the presence and role of human papillomavirus in the development of oesophageal squamous cell carcinoma have been published. We…”
Get full text

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group by Wils, J, Blijham, G.H, Wagener, Th, De Greve, J, Jansen, R.L.H, Kok, T.C, Nortier, J.W.R, Bleiberg, H, Couvreur, M.L, Genicot, B, Baron, B

“…The aim of this study was to investigate whether N-(phosphonacetyl)- l-aspartic acid (PALA) can enhance the activity of low-dose methotrexate (LD-MTX)…”
Get full text

Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer by VAN DER GAAST, A, KOK, T. C, KERKHOFS, L, SIERSEMA, P. D, TILANUS, H. W, SPLINTER, T. A. W

“…We performed this dose-finding study with a fixed dose of cisplatin and increasing doses of paclitaxel given every 2 weeks to determine the maximum tolerable…”
Get full text

Cisplatin and etoposide in oesophageal cancer: a phase II study by KOK, T. C, VAN DER GAAST, A, DEES, J, EYKENBOOM, W. M. H, VAN OVERHAGEN, H, STOTER, G, TILANUS, H. W, SPLINTER, T. A. W

Get full text

Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus by Polee, MB, Kok, TC, Siersema, PD, Tilanus, HW, Splinter, TAW, Stoter, G, Van der Gaast, A

“…The objective of this study was to determine the toxicity and the efficacy of the combination of cisplatin, etoposide, 5-fluorouracil (5-FU) and folinic acid…”
Get full text

Changes in cell wall polysaccharides of green bean pods during development by Stolle-Smits, T, Beekhuizen, J.G, Kok, M.T.C, Pijnenburg, M, Recourt, K, Derksen, J, Voragen, A.G.J

“…The changes in cell wall polysaccharides and selected cell wall-modifying enzymes were studied during the development of green bean (Phaseolus vulgaris L.)…”
Get full text

Prediagnostic transcriptomic markers of Chronic lymphocytic leukemia reveal perturbations 10 years before diagnosis by Chadeau-Hyam, M., Vermeulen, R.C.H., Hebels, D.G.A.J., Castagné, R., Campanella, G., Portengen, L., Kelly, R.S., Bergdahl, I.A., Melin, B., Hallmans, G., Palli, D., Krogh, V., Tumino, R., Sacerdote, C., Panico, S., de Kok, T.M.C.M., Smith, M.T., Kleinjans, J.C.S., Vineis, P., Kyrtopoulos, S.A., Georgiadis, P., Botsivali, M., Papadopoulou, C., Chatziioannou, A., Valavanis, I., Gottschalk, R., van Leeuwen, D., Timmermans, L., Keun, H.C., Athersuch, T.J., Lenner, P., Bendinelli, B., Stephanou, E.G., Myridakis, A., Kogevinas, M., Saberi-Hosnijeh, F., Fazzo, L., de Santis, M., Comba, P., Kiviranta, H., Rantakokko, P., Airaksinen, R., Ruokojarvi, P., Gilthorpe, M.S., Fleming, S., Fleming, T., Tu, Y.-K., Jonsson, B., Lundh, T., Chien, K.-L., Chen, W.J., Lee, W.-C., Hsiao, C.K., Kuo, P.-H., Hung, H., Liao, S.-F.

“…B-cell lymphomas are a diverse group of hematological neoplasms with differential etiology and clinical trajectories. Increased insights in the etiology and…”
Get full text

Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer by van der Gaast, A, Bontenbal, M, Planting, A S, Kok, T C, Splinter, T A

“…The data available on the role of carboplatin and etoposide in breast cancer, especially in patients with no or minimal prior therapy are limited. We performed…”
Get more information

Regression of a great abdominal desmoid tumor by interferon alpha by Geurs, F, Kok, T C

Get more information

13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus by Kok, T C, van der Gaast, A, Splinter, T A

Get full text

Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study by SPLINTER, T. A. W, OBERTOP, H, KOK, T. C, JEEKEL, J

“…From 1980 till 1984 16 patients were entered into a non-randomized pilot study, to investigate the feasibility of five courses of adjuvant 5-fluorouracil,…”
Get full text

Growing teratoma syndrome successfully treated with lymphoblastoid interferon by van der Gaast, A, Kok, T C, Splinter, T A

“…In most instances mature teratoma can be successfully resected following chemotherapy for advanced testicular cancer. However, some patients may eventually die…”
Get more information